Results 171 to 180 of about 24,025 (269)

The LAV‐BPIFB4‐Platelet‐CD47 Axis: A Novel Mechanism Associated With Immune Resilience in Longevity

Aging Cell, Volume 25, Issue 7, July 2026.
Centenarians display elevated CD47+ reticulated platelets, a trait recapitulated in LAV‐BPIFB4 carriers on total platelet pool. LAV‐BPIFB4 drives an early acquirement of CD47 surface expression, enabling platelets to suppress monocyte IL‐6 release. rhLAV‐BPIFB4 phenocopies the effects in non‐genetic carriers, establishing the platelet–CD47–monocyte ...
Elena Ciaglia, Roberta Maria Esposito, Valentina Lopardo, Francesco Montella, Cristina Basile, Roberta Longo, Anna Maciag, Giuseppe Rescigno, Antonio Damato, Francesco Del Plato, Alfonso Finizio, Carmine Vecchione, Albino Carrizzo, Annibale Alessandro Puca   +13 more
wiley   +1 more source

Synergistic effects of luspatercept and cyclosporine A in lower-risk myelodysplastic syndrome with red cell aplasia: Two case insights. [PDF]

Leuk Res Rep
Jo T, Sakai T, Noguchi K, Yamaguchi K, Umemoto K, Abe K, Shigematsu K.   +6 more
europepmc   +1 more source

Real‐World Safety and Efficacy of Avatrombopag in Adults with Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis

European Journal of Haematology, Volume 117, Issue 1, Page 174-185, July 2026.
ABSTRACT Objective This systematic review and meta‐analysis aimed to evaluate the risk of thromboembolic events and assess the overall safety and effectiveness of avatrombopag in adult patients with immune thrombocytopenia using real‐world evidence. Methods A systematic search was conducted following the PRISMA 2020 guidelines.
M. L. Lozano, D. Valcarcel
wiley   +1 more source

Give megs a break: minor DNA stress, platelets in excess. [PDF]

Blood Adv
Kimmerlin Q, Strassel C.
europepmc   +1 more source

Beyond Hemostasis: Platelet Biomarkers and Vascular‐Immune Crosstalk in Dengue

The FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Several biomarkers are associated with platelet activation during dengue virus (DENV) infection. These include serum markers (AST, ALT, ferritin), platelet surface or secreted molecules (P‐selectin, PF4, RANTES, VEGF‐A, CD40L, TREM‐1, TLT‐1), immune and endothelial markers (TREM‐1, Ang‐1, Ang‐2), and viral components such as DENV EIII.
Amanda Beatriz Adriano da Silva‐Alencar, Amanda de Oliveira Matos, Daniel Francisco de Sousa, Jefferson do Carmo Dietz, Eugenio Damaceno Hottz, Marcelle Figueira Marques da Silva‐Sales, Helioswilton Sales‐Campos   +6 more
wiley   +1 more source

Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming. [PDF]

Blood Adv
Carminita E, Camacho V, Branfield S, Walsey E, Barrachina MN, Tabang DN, Lee DH, Becker IC, Brodsky SV, Issa SM, Gendron N, Machado S, Wolberg AS, Steen H, Kerlin B, Machlus KR, Zarjou A, Italiano JE.   +17 more
europepmc   +1 more source

ON THE ALLEGED PHAGOCYTOSIS BY MEGAKARYOCYTES [PDF]

British Journal of Haematology, 1981
openaire   +2 more sources

This Is Not a Myeloproliferative Neoplasm…

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley   +1 more source

Immature platelet fraction and bone marrow findings in hematology. [PDF]

Sci Rep
Yamasaki S, Hashiguchi M, Yoshida-Sakai N, Jojima H, Osaki K, Okamura T, Imamura Y.   +6 more
europepmc   +1 more source

Molecular and Functional Platelet Abnormalities in Myeloproliferative Neoplasms. [PDF]

Cells
Wang AX, Guo BB, Linden MD.
europepmc   +1 more source